RET, Inc.

RET, Inc. specializes in tracheostomy tubes, including both single-use and reusable variants. Their product line includes models like the COMPORT D PLUS, COMPORT C, and COMPORT L, which are designed for long-term airway management in hospitals and clinical environments. These devices are intended to assist patients who require extended respiratory support.

RET, Inc. is headquartered in South Korea. While the country of origin does not directly determine regulatory compliance, it influences the regulatory pathways devices must follow. For example, their tracheostomy tubes listed in eudamed comply with EU requirements, meaning they meet the necessary standards for market placement in the European Economic Area, even if the manufacturer is based outside the EU.

RET, Inc.’s tracheostomy tubes, such as the COMPORT series, fall under Class IIa classification in the EU. This classification is assigned based on risk assessment criteria—Class IIa devices pose a moderate risk to patients and require compliance with specific design controls, clinical evaluations, and conformity assessments to ensure safety and performance before market authorization.

Yes, RET, Inc.’s tracheostomy tubes are listed in the eudamed database, which is the EU’s official registry for medical devices. Listing in eudamed confirms that these devices have undergone the necessary regulatory processes to comply with EU Medical Device Regulations (MDR) or the previous Medical Device Directive (MDD). This transparency helps healthcare providers, regulators, and authorities verify the device’s legal status and compliance before use.